Zymfentra kit is a prescription medicine containing Infliximab, marketed by Celltrion, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in refrigerator at 2°C to 8°C (36°F to 46°F). DO NOT FREEZE. Once the…
Key facts
- Active ingredient (INN)
- Infliximab
- Brand
- Zymfentra
- Dosage form
- Kit
- Packs
- 1 kit, 2 kits, 4 kits and 9 more
- Marketing authorisation holder
- Celltrion
- Manufacturer
- Celltrion
- Origin register
- US FDA, United States
- Storage
- Store in refrigerator at 2°C to 8°C (36°F to 46°F). DO NOT FREEZE. Once the product has been stored at room temperature, it should not be placed back into the refrigerator. If needed, the product may be stored at room temperature at 20°C to 25°C (68°F to 77°F) for up to 14 days with protection from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AB02 Infliximab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2024
- Identifiers
- RxCUI 797544, 2675742, 2675749 +2DailyMed set ID 93a193ab-9f96-4da6-aa7c-31212e81879aNDC 72606-025Application BLA761358
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-01 | Celltrion | 1 March 2024 |
| 2 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-02 | Celltrion | 1 March 2024 |
| 4 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-03 | Celltrion | 1 March 2024 |
| 6 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-04 | Celltrion | 1 March 2024 |
| 1 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-05 | Celltrion | 1 March 2024 |
| 2 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-06 | Celltrion | 1 March 2024 |
| 4 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-07 | Celltrion | 1 March 2024 |
| 6 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-08 | Celltrion | 1 March 2024 |
| 1 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-09 | Celltrion | 1 March 2024 |
| 2 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-10 | Celltrion | 1 March 2024 |
| 4 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-11 | Celltrion | 1 March 2024 |
| 6 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / 1 mL in 1 syringe * 1 mL in 1 packet | 72606-025-12 | Celltrion | 1 March 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Infliximab
Clinical summary
Infliximab is a tumor necrosis factor blocker indicated for crohn's Disease, among other approved uses. It is available as powder for injection, injection and kits for intravenous and subcutaneous use. MedsAcross supplies Infliximab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about InfliximabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- INFLIXIMAB prescribing information (Janssen Biotech) · U.S. National Library of Medicine, DailyMed
- Remicade: European public assessment report (EPAR) · European Medicines Agency
- Flixabi: European public assessment report (EPAR) · European Medicines Agency
Need Zymfentra kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.